Osaic Holdings’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Osaic Holdings’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,402	Closed	-$129K	–	7324
2021 Q1	$129K	Buy	3,402 +2,182	+179%	+$54.4K	﹤0.01%	4156
2020 Q4	$21K	Buy	1,220 +1,000	+455%	+$12.5K	﹤0.01%	5143
2020 Q3	$1K	Hold	220	–	–	﹤0.01%	6153
2020 Q2	$2K	Buy	220 +120	+120%	+$494	﹤0.01%	5873
2020 Q1	$0	Buy	+100	New	+$424	﹤0.01%	6284

Osaic Holdings's FPRX Position: Q2 2021 in Review

Osaic Holdings sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 3,402 shares — an estimated $129K sold.

Osaic Holdings first reported a position in FPRX in Q1 2020 and held it in 5 quarters. The position peaked at $129K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Osaic Holdings reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Osaic Holdings sold 3,402 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $129K.
Osaic Holdings first reported a position in Five Prime Therapeutics, Inc. in Q1 2020 and held it in 5 quarters.
Osaic Holdings's Five Prime Therapeutics, Inc. position peaked at $129K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Osaic Holdings's 13F filing for Q2 2021, filed 2 Aug 2021.